Statement From Alcor CEO Joseph Waynick

PHOENIX, October 4, 2004 -- At the conclusion of a hearing today in Maricopa County Superior Court, Joseph Waynick, CEO of Alcor Life Extension Foundation, made the following statement:

"Alcor has honored the wishes of Ted Williams, his estate, his close friend and personal representative, Al Cassidy, his children, and the Order of the Florida Probate Court. Alcor is further committed to abiding by the orders of Judge Thomas Dunevant III. In fact, Alcor filed for a final judgment to expedite the release of the documents of gift to the plaintiffs. Alcor will comply with the orders of this Court regarding media access to records. It is Alcor's intention to always honor our patients' and members' wishes unless otherwise ordered by a court of law."

About Alcor Life Extension Inc.

The Alcor Life Extension Foundation, a nonprofit organization founded in 1972, is the world leader in cryonics, and cryonics research and technology. Cryonics is the science of using ultra-cold temperatures to suspend and preserve human life. The intent is that technologically advanced scientific procedures will one day be available to revive cryopreserved humans and restore them to good health.

The promise of cryopreservation has taken a quantum leap forward with the ongoing development of molecular nanotechnology and the introduction of vitrification to Alcor's protocols.

One use of nanotechnology is the expectation that cell-sized machines will be developed to repair damage or cure disease at the cellular level, including any potential damage that results from the cryopreservation processes.

Alcor performed its first human cryopreservation in 1976. Since then, Alcor has engaged in long-term patient care as well as cryopreservation procedures. Among Alcor's scientific achievements is the use of advanced cryoprotectant formulas capable of achieving ice-free preservation, known as vitrification.

Today, Alcor is the only full-service cryonics organization in existence. Alcor has more than 680 members from around the world and 65 patients in cryostasis. For more information about Alcor and cryonics, visit